Journal article
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
- Abstract:
-
The prospective multicenter NOA-03 trial, conducted by the Neuro-Oncology Working Group (NOA) of the German Cancer Society, was initiated to define the feasibility and efficacy of single-agent high-dose methotrexate therapy without concomitant radiotherapy in immunocompetent patients with primary central nervous system lymphoma. Thirty-seven patients (median age, 60 years) received 179 biweekly courses of 8 g/m2 methotrexate. Response was assessed after 3 and 6 courses. We had planned to ente...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Annals of neurology
- Volume:
- 51
- Issue:
- 2
- Pages:
- 247-252
- Publication date:
- 2002-02-01
- DOI:
- EISSN:
-
1531-8249
- ISSN:
-
0364-5134
- Source identifiers:
-
240882
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:240882
- UUID:
-
uuid:1e47c2fc-d9d8-4d00-b2c2-b94648c67096
- Local pid:
- pubs:240882
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2002
If you are the owner of this record, you can report an update to it here: Report update to this record